- Home›
- Pharmaceuticals›
- Oncology Products›
- Oncology Injections›
- Cytarabine Injection
Cytarabine Injection
Dosage
Packaging
What is Cytarabine?
Active Ingredients: Cytarabine
Cytarabine Injection is an antineoplastic drug used in cancer chemotherapy. It has been manufactured for intravenous use in the treatment of hematological malignancies, such as acute myeloid leukemia, acute and chronic myelocytic leukemia, meningeal leukemia, erythroleukemia, and non-Hodgkin's lymphoma.
The active ingredient, Cytarabine, is a chemotherapy agent that belongs to a group of drugs known as antimetabolites. It works by interfering with the growth of cancer cells when they absorb the active ingredient. Cytarabine is also known as “cytosine arabinoside.”
AdvaCare Pharma is a trusted global supplier of Cytarabine Injection. We offer a wide range of high-quality and cost-effective oncology medications that are available for distribution. Our factories are GMP-certified and are regularly inspected to ensure they continue to meet the high standards necessary to comply with WHO rules and regulations.
Why are we a trusted Cytarabine manufacturer?
AdvaCare Pharma manufactures a variety of oncology medications, including Cytarabine Injection, at GMP-certified facilities. We are committed to producing cost-effective, high-quality cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. Our global reach extends to over 65 markets, where we supply our products to distributors, hospitals, pharmacies, NGOs, and government institutions.
Uses
What is Cytarabine used for?
It is used to treat hematological malignancies, such as:
- acute and chronic myelocytic leukemia
- acute myeloid leukemia
- erythroleukemia
- meningeal leukemia
- non-Hodgkin's lymphoma
How is Cytarabine Injection used?
This medication has been manufactured as a powder, which is stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by injection into a muscle or vein.
What dose should be given?
For meningeal leukemia, the usual dose is 30 mg/m², given intrathecally.
The usual dose for adults and children depends on the type of disease and the patient's general condition. Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.
Side Effects
As with all pharmaceuticals, some unwanted effects can occur from the use of Cytarabine Injection.
Common side effects include, but may not be limited to:
- nausea and vomiting
- diarrhea
- oral and anal inflammation
- fever
Seek medical attention if the following develop:
- pneumonia
- neuritis
- sore throat
- chest pain
- pericarditis
- alopecia
- dizziness
- pancreatitis
For a comprehensive list of all possible effects, consult a doctor.
If any symptom persists or gets worse, or you notice any other symptoms, please call your doctor immediately.
Precautions
Do NOT use Cytarabine Injection if: • You are allergic to any of the components within the drug.
There are some known drug interactions, so consult with your doctor about any medications you are taking before having an injection with Cytarabine.
The use of Cytarabine during pregnancy or breastfeeding is not recommended because it can be harmful to the fetus or baby. Consult a doctor or healthcare professional before treatment with Cytarabine.
Driving or operating machinery should be okay; however, the medication may cause dizziness in some patients.
You might be interested in...
Why AdvaCare Pharma?
As an industry leader, we are aware of our responsibility to provide affordable and sustainable solutions to improve healthcare worldwide.